Saturday, April 29, 2017

Tag: NYSE:VRX

What are analysts Suggestions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.26/Share in the last quarter where the estimated EPS by analysts was $1.21/share. The difference...

Investors Catching Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.26/Share in the last quarter where the estimated EPS by analysts was $1.21/share. The difference...

Earnings Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.26/Share in the last quarter where the estimated EPS by analysts was $1.21/share. The difference...

Analysts showing optimistic trends for: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.26/Share in the last quarter where the estimated EPS by analysts was $1.21/share. The difference...

What are analysts Suggestions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Investors Catching Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Most Recent analysts Ratings: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Earnings Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Most Recent analysts Ratings: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What are Analysts opinions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...